Low risk of severe COVID‑19 in patients with inflammatory bowel disease: keep calm and take stock

Pol Arch Intern Med. 2021 Mar 29;131(3):222-223. doi: 10.20452/pamw.15903. Epub 2021 Mar 30.

Authors

Mariangela Allocca¹, Vincenzo Craviotto²

Affiliations

¹ Humanitas Clinical and Research Center – IRCCS, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy. mariangela.allocca@hunimed.eu
² Humanitas Clinical and Research Center – IRCCS, Rozzano, Italy

PMID: 33783173
DOI: 10.20452/pamw.15903

No abstract available

Publication types

Editorial
Comment

MeSH terms

COVID-19*
Humans
Inflammatory Bowel Diseases*
Risk Factors
SARS-CoV-2
Seroepidemiologic Studies